Decreased plasma leptin levels in lean and obese Zucker rats after treatment with the serotonin reuptake inhibitor fluoxetine

被引:42
作者
Dryden, S [1 ]
Brown, M [1 ]
King, P [1 ]
Williams, G [1 ]
机构
[1] Univ Liverpool, Dept Med, Diabet & Endocrinol Res Unit, Liverpool L69 3GA, Merseyside, England
基金
英国惠康基金;
关键词
hypothalamus; leptin; obesity; Zucker;
D O I
10.1055/s-2007-978755
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Leptin inhibits feeding, stimulates thermogenesis and decreases body weight. Serotonin reduces food intake when injected into the hypothalamus and may interact with other neurotransmitters in the control of appetite. We therefore investigated the effects of the serotonergic drug fluoxetine, which inhibits serotonin reuptake, on food intake and plasma leptin levels in lean and obese Zucker rats. Fluoxetine significantly reduced food intake in lean and obese rats, both acutely after a single injection (10 mg/kg) and during continuous subcutaneous infusion (10 mg/kg/day for 7 days). plasma leptin levels were reduced after both 4 hours and 7 days of fluoxetine administration in lean and after 7 days in fatty rats (all p < 0.01). We have previously suggested that serotonin may decrease food intake by inhibiting neuropeptide Y neurones, and we further suggest that it also inhibits leptin, possibly by an effect on white adipose tissue.
引用
收藏
页码:363 / 366
页数:4
相关论文
共 30 条
[1]
ANORECTIC ACTIVITY OF FLUOXETINE AND NORFLUOXETINE IN MICE, RATS AND GUINEA-PIGS [J].
ANELLI, M ;
BIZZI, A ;
CACCIA, S ;
CODEGONI, AM ;
FRACASSO, C ;
GARATTINI, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (08) :696-698
[2]
EFFECTS OF INTRACEREBROVENTRICULAR INJECTION OF NEUROPEPTIDE-Y ON ENERGY-METABOLISM [J].
BILLINGTON, CJ ;
BRIGGS, JE ;
GRACE, M ;
LEVINE, AS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (02) :R321-R327
[3]
Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr) [J].
Chua, SC ;
White, DW ;
WuPeng, XS ;
Liu, SM ;
Okada, N ;
Kershaw, EE ;
Chung, WK ;
PowerKehoe, L ;
Chua, M ;
Tartaglia, LA ;
Leibel, RL .
DIABETES, 1996, 45 (08) :1141-1143
[4]
The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats [J].
Dryden, S ;
Frankish, HM ;
Wang, Q ;
Pickavance, L ;
Williams, G .
NEUROSCIENCE, 1996, 72 (02) :557-566
[5]
NEUROPEPTIDE-Y AND ENERGY-BALANCE - ONE-WAY AHEAD FOR THE TREATMENT OF OBESITY [J].
DRYDEN, S ;
FRANKISH, H ;
WANG, Q ;
WILLIAMS, G .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (05) :293-308
[6]
THE SEROTONIN (5-HT) ANTAGONIST METHYSERGIDE INCREASES NEUROPEPTIDE-Y (NPY) SYNTHESIS AND SECRETION IN THE HYPOTHALAMUS OF THE RAT [J].
DRYDEN, S ;
WANG, Q ;
FRANKISH, HM ;
PICKAVANCE, L ;
WILLIAMS, G .
BRAIN RESEARCH, 1995, 699 (01) :12-18
[7]
Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine [J].
Dryden, S ;
Frankish, HM ;
Wang, Q ;
Williams, G .
BRAIN RESEARCH, 1996, 724 (02) :232-237
[8]
DRYDEN S, 1997, CURR OPIN ENDOCRINOL, V4, P124
[9]
Stimulation of 5-HT2A receptors in the paraventricular hypothalamus attenuates neuropeptide Y-induced hyperphagia through activation of corticotropin releasing factor [J].
Grignaschi, G ;
Sironi, F ;
Samanin, R .
BRAIN RESEARCH, 1996, 708 (1-2) :173-176
[10]
SEROTONIN INNERVATION OF NEUROPEPTIDE Y-CONTAINING NEURONS IN THE RAT ARCUATE NUCLEUS [J].
GUY, J ;
PELLETIER, G ;
BOSLER, O .
NEUROSCIENCE LETTERS, 1988, 85 (01) :9-13